Add event to your calendar

Details Price Qty
You must register for the conference before you can register for this workshop.
Already registered for the conference? You can log in here.
  • Extreme R&D: Better treatments for neglected diseases
    14th November 2021 - 15th November 2021
    3:00 pm - 3:40 pm

Speakers

Extreme R&D: Better treatments for neglected diseases

Ilan Moss

Arsenic-based treatments. Toxic antimonials. Expensive and ineffective antifungals.

 

For doctors treating the one billion people at risk of neglected tropical diseases, these have historically been the therapeutic tools available to save lives.

 

It was the deep medical neglect of these diseases – African sleeping sickness, Chagas, kala-azar – that led doctors from Médecins Sans Frontières/Doctors Without Borders to create an organization almost twenty years ago. Called the Drugs for Neglected Diseases initiative (DNDi) the idea was use a not-for-profit R&D model to conduct world-class research in some of the most remote areas of the world.

 

Today this model has delivered – notably an all-oral treatment for sleeping sickness – but much work remains. DNDi’s Ilan Moss will talk through this model of “extreme clinical trials,” from Bandundu province in the Democratic Republic of Congo to labs in the UK researching for new molecules for the world’s most neglected diseases.

Venue:  

Details Price Qty
You must register for the conference before you can register for this workshop.
Already registered for the conference? You can log in here.
  • Extreme R&D: Better treatments for neglected diseases
    14th November 2021 - 15th November 2021
    3:00 pm - 3:40 pm

Speakers

Extreme R&D: Better treatments for neglected diseases

Ilan Moss

Arsenic-based treatments. Toxic antimonials. Expensive and ineffective antifungals.

 

For doctors treating the one billion people at risk of neglected tropical diseases, these have historically been the therapeutic tools available to save lives.

 

It was the deep medical neglect of these diseases – African sleeping sickness, Chagas, kala-azar – that led doctors from Médecins Sans Frontières/Doctors Without Borders to create an organization almost twenty years ago. Called the Drugs for Neglected Diseases initiative (DNDi) the idea was use a not-for-profit R&D model to conduct world-class research in some of the most remote areas of the world.

 

Today this model has delivered – notably an all-oral treatment for sleeping sickness – but much work remains. DNDi’s Ilan Moss will talk through this model of “extreme clinical trials,” from Bandundu province in the Democratic Republic of Congo to labs in the UK researching for new molecules for the world’s most neglected diseases.

Venue:  

Extreme R&D: Better treatments for neglected diseases

Ilan Moss

Arsenic-based treatments. Toxic antimonials. Expensive and ineffective antifungals.

 

For doctors treating the one billion people at risk of neglected tropical diseases, these have historically been the therapeutic tools available to save lives.

 

It was the deep medical neglect of these diseases – African sleeping sickness, Chagas, kala-azar – that led doctors from Médecins Sans Frontières/Doctors Without Borders to create an organization almost twenty years ago. Called the Drugs for Neglected Diseases initiative (DNDi) the idea was use a not-for-profit R&D model to conduct world-class research in some of the most remote areas of the world.

 

Today this model has delivered – notably an all-oral treatment for sleeping sickness – but much work remains. DNDi’s Ilan Moss will talk through this model of “extreme clinical trials,” from Bandundu province in the Democratic Republic of Congo to labs in the UK researching for new molecules for the world’s most neglected diseases.

Details Price Qty
You must register for the conference before you can register for this workshop.
Already registered for the conference? You can log in here.
  • Extreme R&D: Better treatments for neglected diseases
    14th November 2021 - 15th November 2021
    3:00 pm - 3:40 pm

Speakers

Extreme R&D: Better treatments for neglected diseases

Ilan Moss

Arsenic-based treatments. Toxic antimonials. Expensive and ineffective antifungals.

 

For doctors treating the one billion people at risk of neglected tropical diseases, these have historically been the therapeutic tools available to save lives.

 

It was the deep medical neglect of these diseases – African sleeping sickness, Chagas, kala-azar – that led doctors from Médecins Sans Frontières/Doctors Without Borders to create an organization almost twenty years ago. Called the Drugs for Neglected Diseases initiative (DNDi) the idea was use a not-for-profit R&D model to conduct world-class research in some of the most remote areas of the world.

 

Today this model has delivered – notably an all-oral treatment for sleeping sickness – but much work remains. DNDi’s Ilan Moss will talk through this model of “extreme clinical trials,” from Bandundu province in the Democratic Republic of Congo to labs in the UK researching for new molecules for the world’s most neglected diseases.

Venue:  

Details Price Qty
You must register for the conference before you can register for this workshop.
Already registered for the conference? You can log in here.
  • Extreme R&D: Better treatments for neglected diseases
    14th November 2021 - 15th November 2021
    3:00 pm - 3:40 pm

Speakers

Extreme R&D: Better treatments for neglected diseases

Ilan Moss

Arsenic-based treatments. Toxic antimonials. Expensive and ineffective antifungals.

 

For doctors treating the one billion people at risk of neglected tropical diseases, these have historically been the therapeutic tools available to save lives.

 

It was the deep medical neglect of these diseases – African sleeping sickness, Chagas, kala-azar – that led doctors from Médecins Sans Frontières/Doctors Without Borders to create an organization almost twenty years ago. Called the Drugs for Neglected Diseases initiative (DNDi) the idea was use a not-for-profit R&D model to conduct world-class research in some of the most remote areas of the world.

 

Today this model has delivered – notably an all-oral treatment for sleeping sickness – but much work remains. DNDi’s Ilan Moss will talk through this model of “extreme clinical trials,” from Bandundu province in the Democratic Republic of Congo to labs in the UK researching for new molecules for the world’s most neglected diseases.

Venue:  

Menu